CURI
Price
$2.60Alerts
Change
-$0.01 (-0.38%)
Updated
Nov 20, 11:41 AM (EDT)
Capitalization
148.94M
124 days until earnings call
Intraday BUY SELL Signals
SBGI
Price
$14.63Alerts
Change
-$0.03 (-0.20%)
Updated
Nov 20, 11:54 AM (EDT)
Capitalization
989.31M
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CURI vs SBGI

CURI vs SBGI Comparison Chart in %
View a ticker or compare two or three
VS
CURI vs. SBGI commentary
Nov 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURI is a Hold and SBGI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CURI with price predictions
Nov 19, 2026

CURI saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for CURI moved out of overbought territory on November 19, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 44 similar instances where the indicator exited the overbought zone. In 41 of the 44 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CURI moved out of overbought territory on November 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In 16 of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.

CURI moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CURI crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

CURI broke above its upper Bollinger Band on November 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CURI entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2026. You may want to consider a long position or call options on CURI as a result. In 68 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for CURI just turned positive on November 12, 2026. Looking at past instances where CURI's MACD turned positive, the stock continued to rise in 41 of 46 cases over the following month. The odds of a continued upward trend are 89%.

Following a +12.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where CURI advanced for three days, in 175 of 217 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. CURI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.592) is normal, around the industry mean (3.429). CURI's P/E Ratio (1606.560) is considerably higher than the industry average of (112.313). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.298). CURI has a moderately high Dividend Yield (0.135) as compared to the industry average of (0.045). P/S Ratio (2.156) is also within normal values, averaging (8.232).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CURI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

A.I.Advisor
a Summary for SBGI with price predictions
Nov 19, 2026

SBGI's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for SBGI moved out of overbought territory on November 12, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In 23 of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 62 cases where SBGI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBGI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

SBGI broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on SBGI as a result. In 75 of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for SBGI just turned positive on October 29, 2026. Looking at past instances where SBGI's MACD turned positive, the stock continued to rise in 31 of 47 cases over the following month. The odds of a continued upward trend are 66%.

SBGI moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SBGI crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Following a +10.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBGI advanced for three days, in 201 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.603) is normal, around the industry mean (3.429). P/E Ratio (17.316) is within average values for comparable stocks, (112.313). Projected Growth (PEG Ratio) (0.170) is also within normal values, averaging (1.298). Dividend Yield (0.073) settles around the average of (0.045) among similar stocks. P/S Ratio (0.304) is also within normal values, averaging (8.232).

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. SBGI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBGI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

FUNDAMENTALS RATINGS
CURI vs SBGI: Fundamental Ratings
CURI
SBGI
OUTLOOK RATING
1..100
9234
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9059
PRICE GROWTH RATING
1..100
5542
P/E GROWTH RATING
1..100
732
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBGI's Valuation (36) in the Broadcasting industry is somewhat better than the same rating for CURI (96) in the null industry. This means that SBGI’s stock grew somewhat faster than CURI’s over the last 12 months.

SBGI's Profit vs Risk Rating (100) in the Broadcasting industry is in the same range as CURI (100) in the null industry. This means that SBGI’s stock grew similarly to CURI’s over the last 12 months.

SBGI's SMR Rating (59) in the Broadcasting industry is in the same range as CURI (90) in the null industry. This means that SBGI’s stock grew similarly to CURI’s over the last 12 months.

SBGI's Price Growth Rating (42) in the Broadcasting industry is in the same range as CURI (55) in the null industry. This means that SBGI’s stock grew similarly to CURI’s over the last 12 months.

CURI's P/E Growth Rating (7) in the null industry is in the same range as SBGI (32) in the Broadcasting industry. This means that CURI’s stock grew similarly to SBGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CURISBGI
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
66%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
64%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 11 days ago
68%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
COMPARISON
Comparison
Nov 20, 2026
Stock price -- (CURI: $2.61 vs. SBGI: $14.66)
Brand notoriety: CURI and SBGI are both not notable
Both companies represent the Broadcasting industry
Current volume relative to the 65-day Moving Average: CURI: 52% vs. SBGI: 65%
Market capitalization -- CURI: $148.94M vs. SBGI: $989.31M
CURI [@Broadcasting] is valued at $148.94M. SBGI’s [@Broadcasting] market capitalization is $989.31M. The market cap for tickers in the [@Broadcasting] industry ranges from $17.98K to $19.53B. The average market capitalization across the [@Broadcasting] industry is $632.18M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CURI’s FA Score shows that 1 FA rating(s) are green while SBGI’s FA Score has 1 green FA rating(s).

  • CURI’s FA Score: 1 green, 4 red.
  • SBGI’s FA Score: 1 green, 4 red.
According to our system of comparison, SBGI is a better buy in the long-term than CURI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CURI’s TA Score shows that 3 TA indicator(s) are bullish while SBGI’s TA Score has 5 bullish TA indicator(s).

  • CURI’s TA Score: 3 bullish, 7 bearish.
  • SBGI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SBGI is a better buy in the short-term than CURI.

Price Growth

CURI (@Broadcasting) experienced а -8.74% price change this week, while SBGI (@Broadcasting) price change was +0.55% for the same time period.

The average weekly price growth across all stocks in the @Broadcasting industry was -11.33%. For the same industry, the average monthly price growth was -14.01%, and the average quarterly price growth was -22.98%.

Reported Earning Dates

CURI is expected to report earnings on Mar 24, 2027.

SBGI is expected to report earnings on Mar 03, 2027.

Industries' Descriptions

@Broadcasting (-11.33% weekly)

Broadcasting industry includes companies that operate facilities broadcasting radio and/or television programs. Sirius XM Holdings, Inc. (which provides satellite radio and online radio services); Fox Corporation (news and sports broadcasting on TV); and CBS Corporation (TV broadcasting) are some of the behemoths of this industry. The burgeoning digital space has been a disruption for the industry, propelling them to up the ante on their own digital presence.

View a ticker or compare two or three
Interact to see
Advertisement

CURI and

Correlation & Price change

A.I.dvisor tells us that CURI and SSP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CURI and SSP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURI
1D Price
Change %
CURI100%
-4.92%
SSP - CURI
22%
Poorly correlated
-7.10%
SBGI - CURI
21%
Poorly correlated
-1.41%
GTN - CURI
21%
Poorly correlated
-2.26%
BBGI - CURI
20%
Poorly correlated
-3.68%
NXST - CURI
17%
Poorly correlated
-2.07%
More

SBGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBGI has been loosely correlated with GTN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SBGI jumps, then GTN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBGI
1D Price
Change %
SBGI100%
-1.41%
GTN - SBGI
59%
Loosely correlated
-2.26%
FOX - SBGI
51%
Loosely correlated
-2.90%
FOXA - SBGI
49%
Loosely correlated
-2.91%
NXST - SBGI
47%
Loosely correlated
-2.07%
SSP - SBGI
44%
Loosely correlated
-7.10%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UITB45.110.02
+0.04%
VictoryShares Core Intermediate Bond ETF (UITB)
LFAI140.45N/A
N/A
LifeX 2050 Longevity Income ETF (LFAI)
THYM48.38-0.04
-0.09%
T. Rowe Price High Income Municipal ETF (THYM)
IBUF31.04-0.13
-0.41%
Innovator International Developed 10 Buffer ETF - Quarterly (IBUF)
LRND41.42-1.09
-2.57%
NYLIM U.S. Large Cap R&D Leaders ETF (LRND)
Interesting Articles